What the strongest evidence shows: wearables can improve self-management, especially for diabetes and heart conditions
The most comprehensive review here, a 2024 scoping review of 79 intervention studies, found that wearable devices—especially activity trackers and continuous glucose monitors—consistently improve behavioral outcomes like physical activity adherence and diabetes self-management [1]. Diabetes was the most studied condition (23% of studies), and activity trackers were the most common device (53% of studies). The review reported 74 clinical outcomes, 73 behavioral outcomes, and 36 patient technology experience outcomes, showing that wearables affect multiple aspects of care, not just lab numbers [1]. A separate 2026 systematic review of 61 studies confirmed that wearable bands (smartwatches, wristbands) are the dominant form factor, collecting data on heart rate (39% of studies), acceleration (64%), and blood pressure (13%), with primary applications in neurological (34%) and cardiovascular diseases (25%) [3]. These reviews agree that the strongest evidence supports use in diabetes and heart failure, where continuous glucose monitors and heart rate monitors have the most data backing them.
The gap between best-case and typical-case: real-world adoption faces barriers that limit effectiveness
While controlled studies show promise, real-world adoption of wearables for chronic disease management faces significant hurdles. A 2025 qualitative study of 16 elderly patients and 11 healthcare providers in China identified seven major themes, including technology acceptance, device complexity, cost, and data security concerns [6]. Patients and providers recognized the potential benefits but cited usability issues and knowledge gaps as key obstacles [6]. A 2025 randomized crossover trial of 500 elderly patients found that while smartwatches improved monitoring accuracy for heart rate, blood pressure, and sleep quality (P < 0.05), and satisfaction scores were significantly higher, adherence dropped when patients switched back to traditional monitoring, indicating that sustained use requires ongoing motivation and support [4]. The study also noted that user satisfaction and adherence remained higher than baseline even after returning to traditional methods, suggesting a learning effect [4]. These findings highlight that the benefits seen in tightly controlled trials may not translate to everyday settings without addressing barriers like cost, ease of use, and privacy.
Emerging technologies expand possibilities, but most are not yet ready for routine clinical use
Several papers describe novel wearable sensors that could transform monitoring for specific chronic diseases, but these are mostly at the prototype or early clinical testing stage. For example, a 2022 study developed a wearable respiration sensor for chronic kidney disease (CKD) that detects ammonia in breath, showing a 670% response enhancement to 100 ppm NH3 after hydrogen plasma treatment, and successfully tested it in patients with uremia [2]. A 2025 study introduced iCares, a microfluidic wearable device for chronic wound monitoring that measures reactive species (NO, H2O2, O2), pH, and temperature, and tested it in 20 patients with chronic wounds and a murine model, using machine learning to classify wound healing times [5]. Another 2023 review highlighted smart contact lenses for monitoring ophthalmic, metabolic, and neurological diseases via tear biomarkers [7]. While these technologies are exciting, they are not yet widely available or validated in large-scale trials. The 2026 systematic review emphasized that most current wearables are not medically certified, and recommended future research prioritize pragmatic clinical trials with certified devices [3]. Similarly, a 2025 review of e-textiles for continuous glucose monitoring noted that non-invasive methods still face accuracy and reliability challenges due to physiological and environmental interferences [8]. So while the future is promising, the evidence for these advanced sensors is still thin compared to the established data for activity trackers and heart rate monitors.
About These Sources
This answer is built on 8 peer-reviewed studies — published from 2022 to 2026, 6 from 2024 or later, 4 in Q1 journals, collectively cited 204 times — selected as the most relevant from 13 studies that passed quality screening, drawn from 64 papers retrieved from a database of over 500 million.
Sources used in this answer
Wearable Devices for Supporting Chronic Disease Self-Management: Scoping Review
A 2024 scoping review of 79 intervention studies found that diabetes was the most common chronic disease studied (23% of studies), wearable activity trackers were the most used device (53% of studies), and the devices improved behavioral outcomes like physical activity adherence and diabetes self-management.
A Wearable Respiration Sensor for Real-Time Monitoring of Chronic Kidney Disease
A 2022 study developed a wearable respiration sensor for chronic kidney disease (CKD) that detects ammonia in breath, showing a 670% response enhancement to 100 ppm NH3 after hydrogen plasma treatment, and successfully tested it in patients with uremia.
Wearable Devices for Remote Monitoring of Chronic Diseases: Systematic Review.
A 2026 systematic review of 61 studies found that wearable bands (smartwatches, wristbands) are the most common form factor (64% of studies), collecting data on heart rate (39% of studies), acceleration (64%), and blood pressure (13%), with primary applications in neurological (34%) and cardiovascular diseases (25%).
Analysis of the Effectiveness and User Acceptance of Smart Wearable Devices in the Management of Chronic Diseases in the Elderly
A 2025 randomized crossover trial of 500 elderly patients found that smartwatches significantly improved monitoring accuracy for heart rate, blood pressure, and sleep quality (P < 0.05), and satisfaction scores were higher, but adherence dropped when patients switched back to traditional monitoring.
A microfluidic wearable device for wound exudate management and analysis in human chronic wounds
A 2025 study introduced iCares, a microfluidic wearable device for chronic wound monitoring that measures reactive species (NO, H2O2, O2), pH, and temperature, and tested it in 20 patients with chronic wounds and a murine model, using machine learning to classify wound healing times.
Wearable Devices in Elderly Chronic Disease Management: A Qualitative Study of Barriers and Facilitators
A 2025 qualitative study of 16 elderly patients and 11 healthcare providers identified seven themes including technology acceptance, device complexity, cost, and data security as key barriers to wearable adoption for chronic disease management.
Smart Contact Lenses as Wearable Ophthalmic Devices for Disease Monitoring and Health Management
A 2023 comprehensive review described smart contact lenses as wearable ophthalmic devices for monitoring ophthalmic, metabolic, and neurological diseases via tear biomarkers, highlighting current challenges and future possibilities.
Wearable textile sensors for continuous glucose monitoring.
A 2025 review of wearable textile sensors for continuous glucose monitoring found that non-invasive methods (optical, biochemical, biomechanical, thermal) face accuracy and reliability challenges, and proposed multimodal e-textiles for cross-validation.